Kasper Kaagaard Krestensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kasper Kaagaard Krestensen has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ron M. A. Heeren
The Maastricht MultiModal Molecular Imaging (M4I) Institute, Division of Imaging Mass Spectrometry (IMS), Maastricht University, Maastricht, The Netherlands
2 shared publications - Andrej Grgic
The Maastricht MultiModal Molecular Imaging (M4I) Institute, Division of Imaging Mass Spectrometry (IMS), Maastricht University, Maastricht, The Netherlands
1 shared publication - Benjamin Balluff
M4I, The Maastricht MultiModal Molecular Imaging Institute, Maastricht University, Maastricht, The Netherlands
1 shared publication
Latest Publications
- 21 October 2025
- Published by Maastricht University
Innovations in targeted and untargeted spatial omics
- 21 October 2025
- Published by Maastricht University
Innovations in targeted and untargeted spatial omics
- 1 November 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (24) , 6161-6187
State-of-the-art mass spectrometry imaging applications in biomedical research
Mass spectrometry imaging (MSI) has advanced from a niche technique to a widely applied spatial biology tool. This review highlights state-of-the-art MSI application in emerging and the six largest biomedical fields according to a set of criteria.
- 1 November 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (24) , 6161-6187
State-of-the-art mass spectrometry imaging applications in biomedical research
Mass spectrometry imaging (MSI) has advanced from a niche technique to a widely applied spatial biology tool. This review highlights state-of-the-art MSI application in emerging and the six largest biomedical fields according to a set of criteria.
- Open Access
- 16 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Optimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections
Glycans play an important role in biology with multiple cellular functions ranging from cell signaling, mobility and growth to protein folding and localization. The N-glycosylation state within a tissue has been found to vary greatly between healthy and diseased patients and has proven to have an important clinical diagnostic value. Matrix assisted laser-desorption ionization (MALDI) mass spectrometry imaging (MSI) allows for untargeted analysis of biomolecules, including N-glycans, on a tissue section and provides a spatial context of the analyte. Until now, N-glycans have been predominantly analyzed using MALDI MSI on formalin-fixed paraffin embedded (FFPE) tissue sections, however this greatly reduces the clinical applicability, as the FFPE embedding process alters the biological environment of the tissue. Here we developed a protocol that allows for MALDI MSI of N-glycans from fresh frozen tissue that matches the current standard of FFPE analysis. By optimizing several steps in the sample preparation, we see orders of magnitude increase in signal intensity. Furthermore, this method limits delocalization of released N-glycans, thus improving the effective spatial resolution of the label-free molecular images. This protocol provides a novel perspective towards clinical application of MALDI MSI and capitalizes on the diagnostic value of N-glycan analysis.
- 16 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Open AccessOptimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections
Glycans play an important role in biology with multiple cellular functions ranging from cell signaling, mobility and growth to protein folding and localization. The N-glycosylation state within a tissue has been found to vary greatly between healthy and diseased patients and has proven to have an important clinical diagnostic value. Matrix assisted laser-desorption ionization (MALDI) mass spectrometry imaging (MSI) allows for untargeted analysis of biomolecules, including N-glycans, on a tissue section and provides a spatial context of the analyte. Until now, N-glycans have been predominantly analyzed using MALDI MSI on formalin-fixed paraffin embedded (FFPE) tissue sections, however this greatly reduces the clinical applicability, as the FFPE embedding process alters the biological environment of the tissue. Here we developed a protocol that allows for MALDI MSI of N-glycans from fresh frozen tissue that matches the current standard of FFPE analysis. By optimizing several steps in the sample preparation, we see orders of magnitude increase in signal intensity. Furthermore, this method limits delocalization of released N-glycans, thus improving the effective spatial resolution of the label-free molecular images. This protocol provides a novel perspective towards clinical application of MALDI MSI and capitalizes on the diagnostic value of N-glycan analysis.